Neurotech International to Kickstart Clinical Trial of NTI164 Post HREC Approval
January 30, 2024• Interesting Reads, News, SLIDER, Trending News
Neurotech International (ASX: NTI) has secured authorization to commence a notable Phase I/II clinical trial of its proprietary...
Read More → Read More: Neurotech International to Kickstart Clinical Trial of NTI164 Post HREC Approval